To Study the Effects of Aliskiren on Albuminuria and Various Biomarkers in Patients With Nephropathy

Stopped In consequence of termination of ALTITUDE. A number of studies were continued in consultation with the Altitude Data Monitoring Committee.

Conditions

• Non-diabetic Nephropathy

Interventions

• DRUG: Aliskiren
• DRUG: Placebo to Aliskiren
• DRUG: Hydrochlorothiazide (HCTZ)
• DRUG: Placebo to Hydrochlorothiazide (HCTZ)
• DRUG: Ramipril

Sponsor

Novartis Pharmaceuticals